AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildasafe M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Remedy Life Sciences India Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildasafe M 500mg/50mg Tablet

Combiflex DM 500mg/50mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like vision impairment and kidney disease, potentially lowering the risk of cardiovascular events such as stroke or heart attack. Combiflex DM may be administered independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and existing medications. Consuming the tablet with food minimizes digestive discomfort. Consistent daily intake at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. This medication actively regulates blood sugar, preventing future complications. Adherence to your prescribed diet and exercise regimen is crucial for successful diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, sore throat, fatigue, heartburn, hyperhidrosis, and reduced appetite. Low blood sugar (hypoglycemia) is a potential risk, particularly when used with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for all patients. Consult your doctor prior to use if you have a history of liver, kidney, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Inform your physician of all medications you are taking to ensure safety and compatibility. Alcohol should be avoided due to its hypoglycemic effect. Your doctor will monitor your renal function and blood glucose levels throughout treatment.

Uses of Vildasafe M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildasafe M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Administer Vildasafe M 500mg/50mg Tablet with a meal.

Common Side effects of Vildasafe M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildasafe M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Vildasafe M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with meals.

How Vildasafe M 500mg/50mg Tablet works:

Each Vildasafe M 500mg/50mg tablet contains a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Vildasafe M 500mg/50mg Tablet ingestion is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildasafe M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildasafe M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms manifest.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Vildasafe M 500mg/50mg tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Vildasafe M 500mg/50mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildasafe M 500mg/50mg Tablet :

Should you forget a Vildasafe M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildasafe M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildasafe M 500mg/50mg Tablet

Vildasafe M 500mg/50mg Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildasafe M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take additional medication without your doctor's advice.
Vildasafe M 500mg/50mg Tablet is contraindicated in patients with allergies to its components or excipients. It should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildasafe M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildasafe M 500mg/50mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vildasafe M 500mg/50mg Tablets and seek immediate medical attention.
Prolonged use of Vildasafe M 500mg/50mg Tablet can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildasafe M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent side effects to your doctor.
Vildasafe M 500mg/50mg Ta...
90
MRP 104
13% off